Tate & Lyle forecasts flat FY profits as Splenda prices weaken - UPDATE
13th Feb 2014 07:11
- Solid start to Q4 trading - Price falls to deepen for its Splenda sucralose sweetener product - Full-year expected to be broadly in line with last year Food and sweetener company Tate & Lyle said it made a solid start to the final quarter, despite weakness in Splenda sucralose pricing, and expec
Read moreLondon close: Strategists surprised by recent losses in markets
7th Feb 2014 17:08
- Mixed US employment data - Barclays: Fed could refrain from tapering in March - Persimmon and LSE shares power ahead - NIESR: MPC will not raise rates until quarter two of 2015 techMARK 2,790.30 +0.40% FTSE 100 6,571.68 +0.20% FTSE 250 15,865.12 +0.48% The FTSE 100 managed to end the day in the
Read moreBroker tips: Shire, Tate & Lyle, Aquarius Platinum, Acal
7th Feb 2014 12:22
Jefferies has kept its 'buy' rating for pharmaceuticals group Shire saying that it still sees 'attractive growth', but was disappointed by the outcome of clinical trials for the company's major depressive disorder (MDD) treatment, Vyvanse. "We were more optimistic for expanded use of Vyvanse in maj
Read moreLondon midday: Stocks flat as investors await US data with caution
7th Feb 2014 11:41
- Markets flat ahead of US jobs report - Stocks pause after ECB-inspired rally on Thursday - Data disappoints from China, UK, Germany techMARK 2,788.33 +0.33% FTSE 100 6,564.10 +0.09% FTSE 250 15,837.69 +0.30% The FTSE 100 was more or less flat by midday on Friday after trading within a narrow ran
Read moreFriday broker round-up UPDATE
7th Feb 2014 09:30
Acal: N+1 Singer initiates with a target price of 380p and a buy recommendation. AstraZeneca: Societe Generale ups target price from 3030p to 3126p, but still recommends selling. Barratt Developments: Deutsche Bank raises target price from 394p to 480p keeping a buy recommendation. Beazley: Canac
Read moreBroker snap: Tate & Lyle upgraded by JPMorgan on earnings potential
7th Feb 2014 09:09
JPMorgan Cazenove has lifted its rating for Tate & Lyle from 'underweight' to 'overweight', showing optimism about volume and earnings growth at the sugar and sweeteners firm. The bank said that earnings growth at the group level has been held back for the past two years due to investment made in t
Read moreLondon open: Markets pause ahead of US jobs data, stocks flat
7th Feb 2014 08:37
- Non-farm payrolls estimated at 180,000 - China services PMI falls to 50.9 - Tate & Lyle upgraded by JPMorgan to 'overweight' - Shires stops development of depression drug techMARK 2,781.99 +0.10% FTSE 100 6,561.78 +0.05% FTSE 250 15,827.61 +0.24% The FTSE 100 was broadly flat on Friday morning w
Read moreTuesday broker round-up UPDATE
4th Feb 2014 09:20
Alumasc: FinnCap ups target price from 142p to 167p and retains its buy recommendation. Barratt Developments: Barclays increases target price from 444.7p to 471.2p and keeps an overweight rating. Bellway: Barclays raises target price from 1498.1p to 1552.6p, but keeps an underweight rating. Berke
Read moreLondon open: FTSE creeps higher, driven by Sage Group
4th Dec 2013 08:41
- FTSE edges higher - Focus on Friday's US jobs report - Sage races ahead techMARK 2,652.09 +0.44% FTSE 100 6,528.83 -0.06% FTSE 250 15,158.24 +0.03% The FTSE inched higher in early trading, as expected, ignoring declines in both the US and Asia as Sage Group drove the top tier index higher with
Read moreLondon close: Ex-div stocks weigh as investors await Fed minutes
20th Nov 2013 16:17
- MPC warns of 'uncertainties' to recovery - FOMC in focus ahead of minutes - Ex-div stocks finish firmly lower techMARK 2,626.20 -0.68% FTSE 100 6,681.08 -0.25% FTSE 250 15,178.75 -0.57% UK markets finished firmly lower on Wednesday after a choppy session as investors adopted a cautious approach
Read moreFTSE 100 movers: Ex-divi stocks weigh, Aberdeen lifted by Merrill Lynch
20th Nov 2013 14:40
Ex-div stocks were weighing on the FTSE 100 with Vodafone, Tate & Lyle, Next, Carnival and Sainsbury among the stocks trading without the right to their latest payouts. Drinks group Diageo was also under the weather after Chief Executive Ivan Menezes was reported as saying that the "uncertain" mac
Read moreLondon midday: Markets in the red with BoE, Fed in focus
20th Nov 2013 11:33
- BoE voted unanimously on policy at last meeting - MPC attempts to play down rate-hike fears - Taper in focus ahead of FOMC minutes techMARK 2,627.20 -0.64% FTSE 100 6,670.70 -0.41% FTSE 250 15,181.39 -0.55% UK markets were trading in the red on Wednesday after the Bank of England expressed conce
Read moreCarillion Finance Director lowers holding
8th Nov 2013 16:03
Carillion's Group Finance Director, Richard Adam, on Thursday sold, on behalf of his wife, 40,000 shares. Each of these was sold for 309.04p, for a total trade value of £123,616. Adam's stake now stands at 118,238 shares. The disposal was made a week after the support services company announced
Read moreFriday broker round-up UPDATE
8th Nov 2013 09:21
Abcam: Canaccord Genuity moves target price from 396p to 386p and keeps a sell recommendation. N+1 Singer shifts target price from 450p to 445p downgrading to sell. Aberdeen Asset Management: Jefferies lowers target price from 440p to 430p and reiterates a hold recommendation. Anglo American: Gold
Read moreLondon midday: Stocks lower as MPC holds rates, investors await ECB
7th Nov 2013 11:17
- MPC votes to maintain rates, QE - ECB meeting in focus, rate cut eyed - US GDP, jobless claims on tap this afternoon techMARK 2,649.04 -0.17% FTSE 100 6,725.81 -0.24% FTSE 250 15,423.36 +0.13% UK stocks were trading in the red on Thursday morning as investors adopted a cautious approach ahead of
Read more